Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Acq. announced
CC transcript
Director departure
SOLTA MEDICAL INC (SLTM) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/24/2014 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Amended and Restated Certificate of Incorporation of Solta Medical, Inc",
"Amended and Restated By-laws of Solta Medical, Inc",
"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. COMPLETES ACQUISITION OF SOLTA MEDICAL, INC. Laval, Quebec — January 23, 2014 — Valeant Pharmaceuticals International, Inc. today announced the completion of the previously announced transaction in which a wholly-owned subsidiary of Valeant Pharmaceuticals International would acquire Solta Medical, Inc. at a price of $2.92 per share in cash, or approximately $250 million in the aggregate. On January 23, 2014, Valeant announced that it had successfully completed the tender offer for all outstanding shares of common stock of Solta. Valeant announced that it had accepted for payment all shares validly tendered and not properly withdrawn as of the expiration time of the tender offer and would promptly pay for such shares, which represented approxim..."
12/16/2013 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, among Valeant Pharmaceuticals International, Sapphire Subsidiary Corp., Valeant Pharmaceuticals International, Inc. and Solta Medical, Inc",
"VALEANT PHARMACEUTICALS AGREES TO ACQUIRE SOLTA MEDICAL FOR $2.92 PER SHARE IN CASH Combination Creates a Global Leader in Aesthetics Transaction Values Solta at Approximately $250 Million Transaction Expected to Close in the First Quarter of 2014 Laval, Quebec and Hayward, Calif. — December 16, 2013 — Valeant Pharmaceuticals International, Inc. today announced that it has entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Solta Medical, Inc. for $2.92 per share in cash, which represents a 40% premium to Solta's closing share price on December 13, 2013, the last trading day prior to announcement, or a transaction value of approximately $250 million. The transaction is expected to close in the first quarter of 2014 and Valeant expects..."
12/10/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/03/2013 8-K Quarterly results
11/12/2013 8-K Quarterly results
Docs: "Solta Medical Reports Third Quarter 2013 Results and Actions Implemented to Improve Shareholder Returns",
"Transcript of Earnings Call of Solta Medical Inc."
09/05/2013 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Amended and Restated Loan and Security Agreement by and between Solta Medical, Inc. and Silicon Valley Bank"
08/06/2013 8-K Quarterly results
Docs: "Solta Medical Reports Second Quarter 2013 Results"
06/07/2013 8-K Submission of Matters to a Vote of Security Holders
03/21/2013 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Ninth Amendment to Loan and Security Agreement by and between Solta Medical, Inc. and Silicon Valley Bank"
02/19/2013 8-K Quarterly results
Docs: "Solta Medical Reports Fourth Quarter and Full Year 2012 Results"
11/01/2012 8-K Form 8-K - Current report
09/04/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Loan and Security Agreement by and between Solta Medical, Inc. and Silicon Valley Bank",
"Eighth Amendment to Loan and Security Agreement by and between Solta Medical, Inc. and Silicon Valley Bank"
08/27/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment to Stock Purchase Agreement between Solta Medical, Inc. and Medicis Pharmaceutical Corporation"
07/26/2012 8-K Form 8-K - Current report
06/08/2012 8-K Submission of Matters to a Vote of Security Holders
05/01/2012 8-K Quarterly results
Docs: "Solta Medical Reports First Quarter Results"
04/12/2012 8-K Form 8-K - Current report
02/13/2012 8-K Quarterly results
Docs: "Solta Medical Reports Fourth Quarter 2011 Results"
01/17/2012 8-K Form 8-K - Current report
11/18/2011 8-K Form 8-K - Current report
11/03/2011 8-K Form 8-K - Current report
11/02/2011 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "SOLTA AND MEDICIS ANNOUNCE CLOSE OF AGREEMENT FOR LIPOSONIX ®"
11/01/2011 8-K Quarterly results
Docs: "Solta Medical Reports Third Quarter Results"
10/28/2011 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Solta Medical, Inc. Signs Amendment to Expand Its Credit Facility with Silicon Valley Bank to $28 Million"
10/05/2011 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Slide Presentation of Solta Medical, Inc."
09/15/2011 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "MEDICIS AND SOLTA ANNOUNCE AGREEMENT FOR LIPOSONIX ®"
08/02/2011 8-K Form 8-K - Current report
06/08/2011 8-K Form 8-K - Current report
05/03/2011 8-K Form 8-K - Current report
04/25/2011 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Fifth Amendment to Loan and Security Agreement by and between Solta Medical, Inc. and Silicon Valley Bank"
04/11/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/23/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/22/2011 8-K Form 8-K - Current report
02/16/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy